Posted by: Market Watch in Market Information Four minutes in the past Shares of Durect Corp. gained 34.3% in premarket buying and selling
Shares of Durect Corp. gained 34.3% in premarket buying and selling on Tuesday after the corporate mentioned its drug, Posimer, had been accepted by the Meals and Drug Administration as a remedy for ache after a sure kind of shoulder surgical procedure. The drug just isn’t an opioid. The corporate mentioned that greater than 600,000 arthroscopic subacromial decompression surgical procedures are carried out within the U.S. annually. Durect’s inventory is up 9.4% over the previous 12 months, whereas the S&P 500 has gained 17.0%.Market Pulse Tales are Speedy-fire, quick information bursts on shares and markets as they transfer. Go to MarketWatch.com for extra data on this information.
Learn Full Story
